These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3877147)

  • 21. Effect of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on age-related changes in dopamine turnover and transporter function in the mouse striatum.
    Sershen H; Mason MF; Hashim A; Lajtha A
    Eur J Pharmacol; 1985 Jul; 113(1):135-6. PubMed ID: 3876226
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacological effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine receptor system.
    Lau YS; Fung YK
    Brain Res; 1986 Mar; 369(1-2):311-5. PubMed ID: 3486026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment decreases dopamine and increases lipofuscin in mouse retina.
    Mariani AP; Neff NH; Hadjiconstantinou M
    Neurosci Lett; 1986 Dec; 72(2):221-6. PubMed ID: 3492691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced dopamine D2 receptor hypersensitivity in the mouse is transient.
    Peroutka SJ; DeLanney L; Irwin I; Ison PJ; Ricaurte G; Schlegel JR; Langston JW
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):163-71. PubMed ID: 3875136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuation by dopamine uptake blockers of the inhibitory effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and some of its analogs on NADH-linked metabolism in mouse neostriatal slices.
    Ofori S; Heikkila RE; Nicklas WJ
    J Pharmacol Exp Ther; 1989 Oct; 251(1):258-66. PubMed ID: 2571719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors.
    Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC
    Nature; 1984 Oct 4-10; 311(5985):467-9. PubMed ID: 6332989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The neurochemical and clinical effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in small animals.
    Donnan GA; Kaczmarczyk SJ; Solopotias T; Rowe P; Kalnins RM; Vajda FJ; Mendelsohn FA
    Clin Exp Neurol; 1986; 22():155-64. PubMed ID: 3495376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF.
    Elsworth JD; Deutch AY; Redmond DE; Sladek JR; Roth RH
    Brain Res; 1987 Jul; 415(2):293-9. PubMed ID: 3496938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ; Heavens RP; McBride CS
    Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antioxidants fail to inhibit depletion of striatal dopamine by MPTP.
    Baldessarini RJ; Kula NS; Francoeur D; Finklestein SP
    Neurology; 1986 May; 36(5):735. PubMed ID: 3486381
    [No Abstract]   [Full Text] [Related]  

  • 31. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) enhances tryptophan hydroxylase activity in mouse striatum, but not in the frontal cortex.
    Fukuda H; Hara K; Nakamura S; Kimura H; Kameyama M
    Brain Res; 1988 May; 449(1-2):399-402. PubMed ID: 2456132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo effect of MPTP on monoamine oxidase activity in mouse striatum.
    Melamed E; Youdim MB; Rosenthal J; Spanier I; Uzzan A; Globus M
    Brain Res; 1985 Dec; 359(1-2):360-3. PubMed ID: 3878183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Administration of GM1 ganglioside restores the dopamine content in striatum after chronic treatment with MPTP.
    Hadjiconstantinou M; Rossetti ZL; Paxton RC; Neff NH
    Neuropharmacology; 1986 Sep; 25(9):1075-7. PubMed ID: 3490632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amine fluorescence histochemical investigation of the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-induced parkinsonian mice.
    Mizukawa K; Ogawa N; Sora YH
    Res Commun Chem Pathol Pharmacol; 1988 Jan; 59(1):121-8. PubMed ID: 3258432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of hepatic microsomal metabolism as an in vivo detoxication pathway of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Chiba K; Kubota E; Miyakawa T; Kato Y; Ishizaki T
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1108-15. PubMed ID: 3262153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of tyrosine hydroxylation in tissue slices of the rat striatum by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Hirata Y; Nagatsu T
    Brain Res; 1985 Jun; 337(1):193-6. PubMed ID: 2860954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversible serotoninergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse striatum studied by neurochemical and immunohistochemical approaches.
    Hara K; Tohyama I; Kimura H; Fukuda H; Nakamura S; Kameyama M
    Brain Res; 1987 May; 410(2):371-4. PubMed ID: 3297254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
    Harik SI; Schmidley JW; Iacofano LA; Blue P; Arora PK; Sayre LM
    J Pharmacol Exp Ther; 1987 May; 241(2):669-76. PubMed ID: 2437293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra.
    Ricaurte GA; Irwin I; Forno LS; DeLanney LE; Langston E; Langston JW
    Brain Res; 1987 Feb; 403(1):43-51. PubMed ID: 3493827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different toxicity of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) on the nigrostriatal and mesolimbic pathways.
    Ambrosio S; Gerli P; Perego C; Algeri S
    Eur J Pharmacol; 1987 Jan; 133(2):239-41. PubMed ID: 2880741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.